IR@PKUHSC  > 北京大学临床肿瘤学院  > 胃肠肿瘤中心
学科主题临床医学
High level of serum AMBP is associated with poor response to paclitaxel-capecitabine chemotherapy in advanced gastric cancer patients
Huang, Hao1; Han, Yong1; Gao, Jing2; Feng, Junnan1; Zhu, Lei3; Qu, Like1; Shen, Lin2; Shou, Chengchao1
关键词Advanced gastric cancer Serum iTRAQ AMBP Chemoresistance
刊名MEDICAL ONCOLOGY
2013-12-01
DOI10.1007/s12032-013-0748-8
30期:4
收录类别SCI
文章类型Article
WOS标题词Science & Technology
类目[WOS]Oncology
资助者National Basic Research Program of China ; Beijing Municipal Science and Technology Commission Program ; National Basic Research Program of China ; Beijing Municipal Science and Technology Commission Program
研究领域[WOS]Oncology
关键词[WOS]QUANTITATIVE PROTEOMICS ; 1ST-LINE CHEMOTHERAPY ; PROTEIN ; RESISTANCE ; BIOMARKER ; ALPHA(1)-MICROGLOBULIN ; MECHANISMS ; INHIBITOR ; PROGNOSIS ; THERAPY
英文摘要

Gastric cancer is one of the most common human cancers and ranks the second in the global cancer-related mortality. The clinical outcome of patients with advanced gastric cancer (AGC) is markedly dependent on their response to the chemotherapy. Paclitaxel plus capecitabine, as a first-line regimen, is widely administrated in AGC patients, but more than a half of the patients have a poor response, possibly due to their resistance to the treatment. Therefore, it is important to identify potential responders to improve the efficacy of the chemotherapy. In the present study, we used an isobaric tag approach for relative and absolute quantification combined with ESI-QUAD-TOF/MS to identify potential predictive biomarkers for the chemotherapy. We found 211 serum proteins, and confirmed 17 candidates that were differentially present in the progression of disease (PD) group and the partial response (PR) group to the treatment of paclitaxel plus capecitabine. In further validation of the 17 candidates in the set of 12 PD and 12 PR AGC patients, we identified a higher level of AMBP (Alpha-1-Microglobulin/Bikunin Precursor) in the sera of PD patients than of the PR patients assayed by ELISA (9.13 +/- 0.45 vs. 8.11 +/- 0.26 mu g/mL, p = 0.06) and by the Western blotting (relative gray value 396.4 +/- 39.1 vs. 275.0 +/- 34.76, p = 0.03), respectively. The receiver operating characteristics curve showed 75 % sensitivity and 75 % specificity of AMBP in AGC patients treated with the chemotherapy. Our data indicated that the high level of serum AMBP could predict the poor response of the AGC patients treated with the paclitaxel-capecitabine chemotherapy, which could be used as a potential biomarker to identify patients who would benefit from this chemotherapeutic regimen.

语种英语
所属项目编号2010CB5529303 ; Z11110706730000
资助者National Basic Research Program of China ; Beijing Municipal Science and Technology Commission Program ; National Basic Research Program of China ; Beijing Municipal Science and Technology Commission Program
WOS记录号WOS:000327858800015
Citation statistics
Cited Times:13[WOS]   [WOS Record]     [Related Records in WOS]
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/65100
Collection北京大学临床肿瘤学院_胃肠肿瘤中心
作者单位1.Peking Univ, Canc Hosp & Inst, Dept Biochem & Mol Biol, Key Lab Carcinogenesis & Translat Res,Minist Educ, Beijing 100142, Peoples R China
2.Peking Univ, Canc Hosp & Inst, Dept Gastrointestinal Oncol, Key Lab Carcinogenesis & Translat Res,Minist Educ, Beijing 100142, Peoples R China
3.Beijing Prot Innovat Co Ltd, Beijing 101318, Peoples R China
Recommended Citation
GB/T 7714
Huang, Hao,Han, Yong,Gao, Jing,et al. High level of serum AMBP is associated with poor response to paclitaxel-capecitabine chemotherapy in advanced gastric cancer patients[J]. MEDICAL ONCOLOGY,2013,30(4).
APA Huang, Hao.,Han, Yong.,Gao, Jing.,Feng, Junnan.,Zhu, Lei.,...&Shou, Chengchao.(2013).High level of serum AMBP is associated with poor response to paclitaxel-capecitabine chemotherapy in advanced gastric cancer patients.MEDICAL ONCOLOGY,30(4).
MLA Huang, Hao,et al."High level of serum AMBP is associated with poor response to paclitaxel-capecitabine chemotherapy in advanced gastric cancer patients".MEDICAL ONCOLOGY 30.4(2013).
Files in This Item:
There are no files associated with this item.
Related Services
Recommend this item
Bookmark
Usage statistics
Export to Endnote
谷歌学术
谷歌学术Similar articles in
[Huang, Hao]'s Articles
[Han, Yong]'s Articles
[Gao, Jing]'s Articles
百度学术
百度学术Similar articles in
[Huang, Hao]'s Articles
[Han, Yong]'s Articles
[Gao, Jing]'s Articles
必应学术
必应学术Similar articles in
[Huang, Hao]'s Articles
[Han, Yong]'s Articles
[Gao, Jing]'s Articles
Terms of Use
No data!
Social Bookmark/Share
All comments (0)
No comment.
 

Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.